TickerFactsScreenerDevelopers

International Stem Cell CORP (ISCO) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2010: $725.0K2011: $1.62M2012: $1.27M2013: $1.64M2014: $1.92M2015: $2.06M2016: $1.94M2017: $2.12M2018: $4.07M2019: $3.93M2020: $2.78M2021: $2.94M2022: $3.27M2023: $3.18M2024: $3.76M2025: $4.03M$4.03M
2010Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$4.03M+7.1%
2024$3.76M+18.3%
2023$3.18M-2.7%
2022$3.27M+11.4%
2021$2.94M+5.5%
2020$2.78M-29.3%
2019$3.93M-3.3%
2018$4.07M+91.8%
2017$2.12M+9.2%
2016$1.94M-5.4%
2015$2.06M+7.0%
2014$1.92M+16.9%
2013$1.64M+29.2%
2012$1.27M-21.4%
2011$1.62M+123.2%
2010$725.0K—